Advances in targeting voltage-gated sodium channels with small molecules

Area of Science:

• Pharmacology
• Neuroscience
• Molecular Biology

Background:

• Voltage-gated sodium channels (VGSCs) are critical for neuronal excitability and are targets for treating neurological and cardiac conditions.
• Current VGSC inhibitors offer therapeutic benefits but have clinical shortcomings necessitating improved drug development.

Purpose of the Study:

• To review current sodium channel inhibitors, their binding sites, and the biology of sodium channels.
• To explore novel drug discovery strategies for next-generation sodium channel inhibitors.

Main Methods:

• Review of marketed sodium channel inhibitors and their properties.
• Survey of recent medicinal chemistry advancements and automated patch-clamp technologies.
• Critical discussion of strategies for isoform-specific or current-specific small molecule targeting.

Main Results:

• Current inhibitors preferentially target over-excited cells, minimizing side effects.
• Significant need exists for improved sodium channel inhibitors to address clinical limitations.
• Emerging strategies focus on isoform-specific targeting and anomalous current modulation.

Conclusions:

• Despite successes, current sodium channel blockers require advancement.
• Novel medicinal chemistry and high-throughput screening platforms are key to developing improved inhibitors.
• Future research should focus on precise targeting of disease-relevant sodium channel isoforms or currents.